Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients

ANTICANCER RESEARCH

Poprach, A; Fiala, O; Chloupkova, R; Melichar, B; Lakomy, R; Petrakova, K; Zemanova, M; Kopeckova, K; Slaby, O; Studentova, H; Kopecky, J; Kiss, I; Finek, J; Dusek, L; Buchler, T, 2018: Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients. ANTICANCER RESEARCH 38(1), p. 449 - 456, doi: 10.21873/anticanres.12243

CEITEC authors:

Prof. Ondřej Slabý, Ph.D.
Prof. Igor Kiss, Ph.D.